Circulating miR-126 as a Novel Biomarker for Post Myocardial Infarction Remodeling

NCT01875484 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2015-07-30

No results posted yet for this study

Summary

Purpose: The purpose of this study is to evaluate the impact of circulating miR-126 on left ventricular remodeling and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Conditions

Sponsors & Collaborators

  • Qianfoshan Hospital

    collaborator OTHER
  • Jinan Central Hospital

    collaborator OTHER
  • Shandong Provincial Hospital

    collaborator OTHER_GOV
  • The Second Hospital of Shandong University

    collaborator OTHER
  • Ruijin Hospital

    collaborator OTHER
  • Qingdao University

    collaborator OTHER
  • Shandong Provincial Medical Imaging Institute of Shandong University

    collaborator UNKNOWN
  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER
  • Heze Municipal Hospital

    collaborator OTHER
  • Jining Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Qihe People's Hospital

    collaborator UNKNOWN
  • Central Hospital of Zibo

    collaborator OTHER
  • Weihai Municipal Hospital

    collaborator OTHER
  • Beijing Friendship Hospital

    collaborator OTHER
  • Binzhou Medical University

    collaborator OTHER
  • Beijing Hospital

    collaborator OTHER_GOV
  • Qilu Hospital of Shandong University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2015-06-30
Completion
2015-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01875484 on ClinicalTrials.gov